Literature DB >> 25504012

Two-week normobaric intermittent-hypoxic exposures stabilize cerebral perfusion during hypocapnia and hypercapnia.

Peizhen Zhang1, Xiangrong Shi2, H Fred Downey3.   

Abstract

The effect of moderately extended, intermittent-hypoxia (IH) on cerebral perfusion during changes in CO2 was unknown. Thus, we assessed the changes in cerebral vascular conductance (CVC) and cerebral tissue oxygenation (ScO2) during experimental hypocapnia and hypercapnia following 14-day normobaric exposures to IH (10% O2). CVC was estimated from the ratio of mean middle cerebral arterial blood flow velocity (transcranial Doppler sonography) to mean arterial pressure (tonometry), and ScO2 in the prefrontal cortex was monitored by near-infrared spectroscopy. Changes in CVC and ScO2 during changes in partial pressure of end-tidal CO2 (PETCO2, mass spectrometry) induced by 30-s paced-hyperventilation (hypocapnia) and during 6-min CO2 rebreathing (hypercapnia) were compared before and after 14-day IH exposures in eight young nonsmokers. Repetitive IH exposures reduced the ratio of %ΔCVC/ΔPETCO2 during hypocapnia (1.00 ± 0.13 vs 1.94 ± 0.35 vs %/mmHg, P = 0.026) and the slope of ΔCVC/ΔPETCO2 during hypercapnia (1.79 ± 0.37 vs 2.97 ± 0.64 %/mmHg, P = 0.021), but had no significant effect on ΔScO2PETCO2. The ventilatory response to hypercapnia during CO2 rebreathing was significantly diminished following 14-day IH exposures (0.83 ± 0.07 vs 1.14 ± 0.09 L/min/mmHg, P = 0.009). We conclude that repetitive normobaric IH exposures significantly diminish variations of cerebral perfusion in response to hypercapnia and hypocapnia without compromising cerebral tissue oxygenation. This IH-induced blunting of cerebral vasoreactivity during CO2 variations helps buffer excessive oscillations of cerebral underperfusion and overperfusion while sustaining cerebral O2 homeostasis.
© 2014 by the Society for Experimental Biology and Medicine.

Entities:  

Keywords:  CO2 variations; Cerebral tissue oxygenation; ventilatory response

Mesh:

Year:  2014        PMID: 25504012      PMCID: PMC4935400          DOI: 10.1177/1535370214562339

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  42 in total

1.  Cerebrovascular response to carbon dioxide in patients with congestive heart failure.

Authors:  Ailiang Xie; James B Skatrud; Rami Khayat; Jerome A Dempsey; Barbara Morgan; Douglas Russell
Journal:  Am J Respir Crit Care Med       Date:  2005-05-18       Impact factor: 21.405

2.  Cerebral autoregulation is preserved during orthostatic stress superimposed with systemic hypotension.

Authors:  Hong Guo; Nancy Tierney; Frederic Schaller; Peter B Raven; Scott A Smith; Xiangrong Shi
Journal:  J Appl Physiol (1985)       Date:  2006-01-19

3.  Reduced vasomotor reactivity in cerebral microangiopathy : a study with near-infrared spectroscopy and transcranial Doppler sonography.

Authors:  C Terborg; F Gora; C Weiller; J Röther
Journal:  Stroke       Date:  2000-04       Impact factor: 7.914

4.  Morning attenuation in cerebrovascular CO2 reactivity in healthy humans is associated with a lowered cerebral oxygenation and an augmented ventilatory response to CO2.

Authors:  Kevin J Cummings; Marianne Swart; Philip N Ainslie
Journal:  J Appl Physiol (1985)       Date:  2007-02-22

5.  Normobaric hypoxia conditioning reduces blood pressure and normalizes nitric oxide synthesis in patients with arterial hypertension.

Authors:  Nadezhda P Lyamina; Svetlana V Lyamina; Valery N Senchiknin; Robert T Mallet; H Fred Downey; Eugenia B Manukhina
Journal:  J Hypertens       Date:  2011-11       Impact factor: 4.844

6.  Intermittent hypoxic training protects canine myocardium from infarction.

Authors:  Pu Zong; Srinath Setty; Wei Sun; Rodolfo Martinez; Johnathan D Tune; Igor V Ehrenburg; Elena N Tkatchouk; Robert T Mallet; H Fred Downey
Journal:  Exp Biol Med (Maywood)       Date:  2004-09

7.  Hypercapnia-induced cerebral hyperperfusion: an underrecognized clinical entity.

Authors:  J M Pollock; A R Deibler; C T Whitlow; H Tan; R A Kraft; J H Burdette; J A Maldjian
Journal:  AJNR Am J Neuroradiol       Date:  2008-10-14       Impact factor: 3.825

8.  Intermittent hypoxia reduces cerebrovascular sensitivity to isocapnic hypoxia in humans.

Authors:  Jordan S Querido; Jesse B Godwin; A William Sheel
Journal:  Respir Physiol Neurobiol       Date:  2007-11-17       Impact factor: 1.931

9.  Ventilatory, cerebrovascular, and cardiovascular interactions in acute hypoxia: regulation by carbon dioxide.

Authors:  Philip N Ainslie; Marc J Poulin
Journal:  J Appl Physiol (1985)       Date:  2004-03-05

10.  Cerebral vasomotor reactivity is reduced in patients with erectile dysfunction.

Authors:  Edoardo Vicenzini; Marta Altieri; Paolo Maria Michetti; Maria Chiara Ricciardi; Mauro Ciccariello; Hossein Shahabadi; Francesco Puccinelli; Gian Luigi Lenzi; Vittorio Di Piero
Journal:  Eur Neurol       Date:  2008-06-05       Impact factor: 1.710

View more
  4 in total

1.  Sleep-disordered breathing is associated with brain vascular reactivity in spinal cord injury.

Authors:  Jordan W Squair; Amanda H X Lee; Zoe K Sarafis; Geoff Coombs; Otto Barak; Jacquelyn J Cragg; Tanja Mijacika; Renata Pecotic; Andrei V Krassioukov; Zoran Dogas; Zeljko Dujic; Aaron A Phillips
Journal:  Neurology       Date:  2019-11-06       Impact factor: 9.910

2.  Intermittent hypoxia training protects cerebrovascular function in Alzheimer's disease.

Authors:  Eugenia B Manukhina; H Fred Downey; Xiangrong Shi; Robert T Mallet
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-10

3.  Intermittent hypoxia improves cognition and reduces anxiety-related behavior in APP/PS1 mice.

Authors:  Sheng-Xi Meng; Bing Wang; Wen-Tao Li
Journal:  Brain Behav       Date:  2019-12-26       Impact factor: 2.708

4.  A prospective cohort study about the effect of repeated living high and working higher on cerebral autoregulation in unacclimatized lowlanders.

Authors:  Laura C Graf; Sara E Hartmann; Mona Lichtblau; Lara Muralt; Patrick R Bader; Ivan Lopez; Jean M Rawling; Silvia Ulrich; Konrad E Bloch; Marc J Poulin; Michael Furian
Journal:  Sci Rep       Date:  2022-02-15       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.